The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...

Surgery is essential for the effective management of bronchiectasis. Segmentectomy, while a challenging procedure, has become ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Discover the 5 devastating long-term effects of measles beyond the rash, including immune system damage that leaves you ...

Vast Therapeutics, a clinical-stage life science company, today announced that the U.S. Food and Drug Administration has ...

Learn more about whether Alvotech or Grifols, S.A. is a better investment based on AAII's A+ Investor grades, which compare ...

Although measles is seen as a contagious viral disease that passes quickly, it can also cause damage that leaves long-term ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule ...

Hospital Authority consultant confident residents won’t argue with healthcare workers over ‘critical’ or ‘emergency’ status ...

RIPSA interests repurchased Term loan facility increased to $450 million with more favorable terms Access to up to an additional $200 million LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) ...

StockNews.com cut shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a report issued on Friday. Separately, B. Riley started coverage on Electromed in a ...